🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
FAQ|Rules|Members
Log In Register
Forums›Cardiovascular Outcomes

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results

Cardiovascular Outcomes

87 threads · 1.2K posts
D
Study SELECT trial: 20% MACE reduction — mechanistic deep dive
Dr.CardioMD · Yesterday at 11:34 PM
7Replies
63Views
D
Dr.CardioMD
Yesterday at 11:34 PM
D
Study Semaglutide cardiovascular benefit independent of weight loss
Dr.CardioMD · Yesterday at 9:52 PM
11Replies
302Views
D
Dr.CardioMD
Yesterday at 9:52 PM
D
Study STEP-HFpEF: semaglutide in heart failure with preserved EF
Dr.CardioMD · Yesterday at 5:10 PM
15Replies
378Views
D
Dr.CardioMD
Yesterday at 5:10 PM
D
Study GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data
Dr.MetabolicMD · Yesterday at 9:29 AM
18Replies
410Views
D
Dr.MetabolicMD
Yesterday at 9:29 AM
LA
New Lp(a) on GLP-1 agonists — any impact on this risk factor?
LipidDoc_ATL · Thursday at 10:49 PM
8Replies
202Views
LA
LipidDoc_ATL
Thursday at 10:49 PM
D
Study Blood pressure reduction mechanisms on GLP-1 — natriuresis
Dr.RenalNash · Thursday at 9:10 AM
18Replies
335Views
D
Dr.RenalNash
Thursday at 9:10 AM
LA
Study ApoB reduction on tirzepatide — SURPASS lipid substudies
LipidDoc_ATL · Wednesday at 4:31 PM
13Replies
243Views
LA
LipidDoc_ATL
Wednesday at 4:31 PM
D
Study Anti-thrombotic properties of GLP-1 receptor activation
Dr.CardioMD · Tuesday at 8:54 PM
17Replies
252Views
D
Dr.CardioMD
Tuesday at 8:54 PM

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
HD
Study SELECT cost-effectiveness — NNT analysis for MACE prevention
HealthEcon_DC · Monday at 10:17 PM
13Replies
458Views
HD
HealthEcon_DC
Monday at 10:17 PM
D
New Heart rate increase on GLP-1 — clinical significance assessment
Dr.CardioMD · Sunday at 8:41 PM
2Replies
194Views
D
Dr.CardioMD
Sunday at 8:41 PM
D
Study SOUL trial preliminary data — semaglutide in T2DM cardiovascular outcomes
Dr.CardioMD · Saturday at 4:06 PM
20Replies
546Views
D
Dr.CardioMD
Saturday at 4:06 PM
D
Study GLP-1 and atrial fibrillation risk — emerging signal or noise?
Dr.RaviCardio · Mar 6, 2026
15Replies
423Views
D
Dr.RaviCardio
Mar 6, 2026
D
Study Echocardiographic changes on GLP-1 — LV mass and diastolic function
Dr.CardioMD · Mar 4, 2026
20Replies
460Views
D
Dr.CardioMD
Mar 4, 2026
D
Study Coronary artery calcium score changes on GLP-1 — 2-year follow-up
Dr.RaviCardio · Mar 3, 2026
14Replies
356Views
D
Dr.RaviCardio
Mar 3, 2026
D
New GLP-1 and peripheral arterial disease — claudication improvement data
Dr.CardioMD · Mar 1, 2026
8Replies
449Views
D
Dr.CardioMD
Mar 1, 2026
123…8
Users browsing this forum: Admin, Dr.Martinez, mike_mod, sarah.morrison and 13 guests
CompoundTalk Weekly Digest

Top threads, new research, and vendor alerts every Friday.

ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register